The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Open accessAbstract
Huntington’s disease (HD) is one of the few neurodegenerative diseases with a known genetic cause, knowledge that has enabled the creation of animal models using genetic manipulations that aim to recapitulate HD pathology. The study of behavioral and neuropathological phenotypes of these HD models, however, has been plagued by inconsistent results across laboratories stemming from the lack of standardized husbandry and testing conditions, in addition to the intrinsic differences between the models. We have compared different HD models using standardized conditions to identify the most robust phenotypic differences, best suited for preclinical therapeutic efficacy studies. With a battery of tests of sensory-motor function, such as the open field and prepulse inhibition tests, we replicate previous results showing a strong and progressive behavioral deficit in the R6/2 line with an average of 129 CAG repeats in a mixed CBA/J and C57BL/6J background. We present the first behavioral characterization of a new model, an R6/2 line with an average of 248 CAG repeats in a pure C57BL/6J background, which also showed a progressive and robust phenotype. The BACHD in a FVB/N background showed robust and progressive behavioral phenotype, while the YAC128 full-length model on either an FVB/N or a C57BL/6J background generally showed milder deficits. Finally, the HdhQ111 knock-in mouse on a CD1 background showed very mild deficits. This first extensive standardized cross-characterization of several HD animal models under standardized conditions highlights several behavioral outcomes, such as hypoactivity, amenable to standardized preclinical therapeutic drug screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationMangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Self-citationA polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,347
Using SAS PROC MIXED to Fit Multilevel Models, Hierarchical Models, and Individual Growth Models
Singer, J. D. (1998) · Journal of Educational and Behavioral Statistics · doi:10.2307/1165280 · Cited by 1,092
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Self-citationGene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
Gerlai, R. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20020-7 · Cited by 881
Bowes, C., Li, T., Danciger, M., Baxter, L. C., Applebury, M. L., & Farber, D. B. (1990) · Nature · doi:10.1038/347677a0 · Cited by 852
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Slow, E. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg169 · Cited by 800
Gray, M., Shirasaki, D. I., Cepeda, C., Andre, V. M., Wilburn, B., Lu, X.-H., Tao, J., Yamazaki, I., Li, S.-H., Sun, Y. E., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0857-08.2008 · Cited by 613
Self-citationNeurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C.-H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Delaying the onset of Huntington's in mice
van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000) · Nature · doi:10.1038/35008142 · Cited by 511
Wheeler, V. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.503 · Cited by 469
Self-citationSwerdlow, N. R., Paulsen, J., Braff, D. L., Butters, N., Geyer, M. A., & Swenson, M. R. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.2.192 · Cited by 441
Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease
Morton, A. J., Wood, N. I., Hastings, M. H., Hurelbrink, C., Barker, R. A., & Maywood, E. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3842-04.2005 · Cited by 403
Self-citationLione, L. A., Carter, R. J., Hunt, M. J., Bates, G. P., Morton, A. J., & Dunnett, S. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10428.1999 · Cited by 384
Self-citationInbred strain differences in prepulse inhibition of the mouse startle response
Paylor, R., & Crawley, J. N. (1997) · Psychopharmacology · doi:10.1007/s002130050333 · Cited by 379
Spires, T. L., Grote, H. E., Varshney, N. K., Cordery, P. M., van Dellen, A., Blakemore, C., & Hannan, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1658-03.2004 · Cited by 365
Environmental enrichment slows disease progression in R6/2 Huntington's disease mice
Hockly, E., Cordery, P. M., Woodman, B., Mahal, A., Van Dellen, A., Blakemore, C., Lewis, C. M., Hannan, A. J., & Bates, G. P. (2002) · Annals of Neurology · doi:10.1002/ana.10094 · Cited by 330
Self-citationKuhn, A., Goldstein, D. R., Hodges, A., Strand, A. D., Sengstag, T., Kooperberg, C., Becanovic, K., Pouladi, M. A., Sathasivam, K., Cha, J.-H. J., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm133 · Cited by 328
Self-citationVan Raamsdonk, J. M., Pearson, J., Slow, E. J., Hossain, S. M., Leavitt, B. R., & Hayden, M. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0590-05.2005 · Cited by 317
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Self-citationSlow, E. J., Graham, R. K., Osmand, A. P., Devon, R. S., Lu, G., Deng, Y., Pearson, J., Vaid, K., Bissada, N., Wetzel, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503634102 · Cited by 275
Menalled, L. B., Sison, J. D., Wu, Y., Olivieri, M., Li, X.-J., Li, H., Zeitlin, S., & Chesselet, M.-F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08266.2002 · Cited by 219
Self-citationTelenius, H., Kremer, H. P. H., Thellmann, J., Andrew, S. E., Almqvist, E., Anvret, M., Greenberg, C., Greenberg, J., Lucotte, G., Squltierl, F., et al. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.10.1535 · Cited by 203
Lazic, S. E., Grote, H. E., Blakemore, C., Hannan, A. J., van Dellen, A., Phillips, W., & Barker, R. A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04715.x · Cited by 173
Woodman, B., Butler, R., Landles, C., Lupton, M. K., Tse, J., Hockly, E., Moffitt, H., Sathasivam, K., & Bates, G. P. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.11.004 · Cited by 166
Self-citationThe gait abnormality of Huntington's disease
Koller, W. C., & Trimble, J. (1985) · Neurology · doi:10.1212/wnl.35.10.1450 · Cited by 161
Standardization and statistical approaches to therapeutic trials in the R6/2 mouse
Hockly, E., Woodman, B., Mahal, A., Lewis, C. M., & Bates, G. P. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00185-0 · Cited by 148
Self-citationMorton, A. J., Lagan, M., Skepper, J. N., & Dunnett, S. B. (2000) · Journal of Neurocytology · doi:10.1023/a:1010887421592 · Cited by 138
Self-citationGlass, M., van Dellen, A., Blakemore, C. B., Hannan, A. J., & Faull, R. L. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00595-5 · Cited by 138
Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing
Hickey, M. A., GALLANT, K., GROSS, G., LEVINE, M., & Chesselet, M.-F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.024 · Cited by 129
Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice
Morton, A. J., Glynn, D., Leavens, W., Zheng, Z., Faull, R. L. M., Skepper, J. N., & Wight, J. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.015 · Cited by 127
Self-citationvan Dellen, A., Cordery, P. M., Spires‐Jones, T. L., Blakemore, C. B., & Hannan, A. J. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-34 · Cited by 127
Modifier genes and protective alleles in humans and mice.
Nadeau, J. (2003) · Current Opinion in Genetics and Development · doi:10.1016/s0959-437x(03)00061-3 · Cited by 118
Raamsdonk, J. M. V., Metzler, M., Slow, E., Pearson, J., Schwab, C., Carroll, J. B., Graham, R. K., Leavitt, B. R., & Hayden, M. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.010 · Cited by 114
Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington’s disease
NANCE, M. A., Mathias-Hagen, V., Breningstall, G. N., Wick, M. J., & McGlennen, R. C. (1999) · Neurology · doi:10.1212/wnl.52.2.392 · Cited by 113
Body weight is modulated by levels of full-length Huntingtin
Raamsdonk, J. M. V., Gibson, W. T., Pearson, J., Murphy, Z., Lu, G., Leavitt, B. R., & Hayden, M. R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl072 · Cited by 112
Lloret, A., Dragileva, E., Teed, A. M., Espinola, J. A., Fossale, E., Gillis, T., Lopez, E., Myers, R. H., MacDonald, M. E., & Wheeler, V. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl125 · Cited by 105
Self-citationSpampanato, J. G., Gu, X., Yang, X. W., & Módy, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.020 · Cited by 93
Self-citationCAG repeat lengths ≥ 335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse
Dragatsis, I., Goldowitz, D., Mar, N. D., Deng, Y. P., Meade, C. A., Liu, L., Sun, Z., Dietrich, P., Yue, J., & Reiner, A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.009 · Cited by 92
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice
Schilling, G., Savonenko, A. V., Coonfield, M. L., Morton, J. L., Vorovich, E. B., Gale, A., Neslon, C., Chan, N., Eaton, M., Fromholt, D., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.003 · Cited by 92
Raamsdonk, J. M. V., Pearson, J., Murphy, Z., Hayden, M. R., & Leavitt, B. R. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-80 · Cited by 64
Comparative study of emotional behaviour in three inbred strains of mice
Kopp, C., Vogel, E., & Misslin, R. (1999) · Behavioural Processes · doi:10.1016/s0376-6357(99)00057-1 · Cited by 59
Sathasivam, K., Amaechi, I., Mangiarini, L., & Bates, G. P. (1997) · Human Genetics · doi:10.1007/s004390050432 · Cited by 54
Self-citationMinimizing Variation Due to Genotype and Environment
Argmann, C., & Auwerx, J. H. (2006) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb29a02s73 · Cited by 6
Cited by
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,743
Saudou, F., & Humbert, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.003 · Cited by 951
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Rodent models in neuroscience research: is it a rat race?
Ellenbroek, B., & Youn, J. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026120 · Cited by 627
Animal models of human disease: challenges in enabling translation
McGonigle, P., & Ruggeri, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.006 · Cited by 610
Metadata
- Authors
- Menalled, L., El-Khodor, B. F., Patry, M., Suárez-Fariñas, M., Orenstein, S. J., Zahasky, B., Leahy, C., Wheeler, V., Yang, X. W., MacDonald, M., Morton, A. J., Bates, G., Leeds, J., Park, L., Howland, D., Signer, E., Tobin, A., & Brunner, D.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 35
- Issue
- 3
- Pages
- 319-336
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2091011066
- Cited by
- 324
- References
- 45
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.